Literature DB >> 17255852

A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens.

Jeffrey A Gold1, Binaya Rimal, Anna Nolan, Lewis S Nelson.   

Abstract

OBJECTIVE: Patients with severe alcohol withdrawal and delirium tremens are frequently resistant to standard doses of benzodiazepines. Case reports suggest that these patients have a high incidence of requiring intensive care and many require mechanical ventilation. However, few data exist on treatment strategies and outcomes for these subjects in the medical intensive care unit (ICU). Our goal was a) to describe the outcomes of patients admitted to the medical ICU solely for treatment of severe alcohol withdrawal and b) to determine whether a strategy of escalating doses of benzodiazepines in combination with phenobarbital would improve outcomes.
DESIGN: Retrospective cohort study.
SETTING: Inner-city municipal hospital. PATIENTS: Subjects admitted to the medical ICU solely for the treatment of severe alcohol withdrawal.
INTERVENTIONS: Institution of guidelines emphasizing escalating doses of diazepam in combination with phenobarbital.
MEASUREMENTS AND MAIN RESULTS: Preguideline (n = 54) all subjects were treated with intermittent boluses of diazepam with an average total and maximal individual dose of 248 mg and 32 mg, respectively; 17% were treated with phenobarbital. Forty-seven percent required intubation due to inability to achieve adequate sedation and need for constant infusion of sedative-hypnotics. Intubated subjects had longer length of stay (5.6 vs. 3.4 days; p = .09) and higher incidence of nosocomial pneumonia (42 vs. 21% p = .08). Postguideline (n = 41) there were increases in maximum individual dose of diazepam (32 vs. 86 mg; p = .001), total amount of diazepam (248 vs. 562 mg; p = .001), and phenobarbital use (17 vs. 58%; p = .01). This was associated with a reduction in the need for mechanical ventilation (47 vs. 22%; p = .008), with trends toward reductions in ICU length of stay and nosocomial pneumonia.
CONCLUSIONS: Patients admitted to a medical ICU solely for treatment of severe alcohol withdrawal have a high incidence of requiring mechanical ventilation. Guidelines emphasizing escalating bolus doses of diazepam, and barbiturates if necessary, significantly reduced the need for mechanical ventilation and showed trends toward reductions in ICU length of stay and nosocomial infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255852      PMCID: PMC3417045          DOI: 10.1097/01.CCM.0000256841.28351.80

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  41 in total

1.  High-dose intravenous benzodiazepine.

Authors:  C Dill; S Shin
Journal:  Acad Emerg Med       Date:  2000-03       Impact factor: 3.451

Review 2.  International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-associated Pneumonia.

Authors:  J Rello; J A Paiva; J Baraibar; F Barcenilla; M Bodi; D Castander; H Correa; E Diaz; J Garnacho; M Llorio; M Rios; A Rodriguez; J Solé-Violán
Journal:  Chest       Date:  2001-09       Impact factor: 9.410

3.  Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABAA receptors.

Authors:  Elisabetta Cagetti; Jing Liang; Igor Spigelman; Richard W Olsen
Journal:  Mol Pharmacol       Date:  2003-01       Impact factor: 4.436

4.  A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: lofexidine is not a useful adjunct to chlordiazepoxide.

Authors:  F Keaney; J Strang; M Gossop; E J Marshall; M Farrell; S Welch; B Hahn; A Gonzalez
Journal:  Alcohol Alcohol       Date:  2001 Sep-Oct       Impact factor: 2.826

5.  Refractory delirium tremens treated with propofol: a case series.

Authors:  C McCowan; P Marik
Journal:  Crit Care Med       Date:  2000-06       Impact factor: 7.598

Review 6.  Neurosteroids, GABAA receptors, and ethanol dependence.

Authors:  Paolo Follesa; Francesca Biggio; Giuseppe Talani; Luca Murru; Mariangela Serra; Enrico Sanna; Giovanni Biggio
Journal:  Psychopharmacology (Berl)       Date:  2005-09-15       Impact factor: 4.530

7.  Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial.

Authors:  Jean-Bernard Daeppen; Pascal Gache; Ulrika Landry; Eva Sekera; Verena Schweizer; Stéphane Gloor; Bertrand Yersin
Journal:  Arch Intern Med       Date:  2002-05-27

8.  Impact of an alcohol withdrawal syndrome practice guideline on surgical patient outcomes.

Authors:  Karen M Stanley; Celene M Amabile; Kit N Simpson; Deborah Couillard; E Douglas Norcross; Cathy L Worrall
Journal:  Pharmacotherapy       Date:  2003-07       Impact factor: 4.705

9.  Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early?

Authors:  Jason B Hack; Robert S Hoffmann; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2006-06

10.  The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure.

Authors:  Philip Gorwood; Frédéric Limosin; Philippe Batel; Michel Hamon; Jean Adès; Claudette Boni
Journal:  Biol Psychiatry       Date:  2003-01-01       Impact factor: 13.382

View more
  21 in total

Review 1.  Alcohol-use disorders in the critically ill patient.

Authors:  Marjolein de Wit; Drew G Jones; Curtis N Sessler; Marya D Zilberberg; Michael F Weaver
Journal:  Chest       Date:  2010-10       Impact factor: 9.410

2.  Alcohol withdrawal prevention: a randomized evaluation of lorazepam and ethanol--a pilot study.

Authors:  Joyce E Fullwood; Zhila Mostaghimi; Christopher B Granger; Jeffrey B Washam; Wanda Bride; Yanfang Zhao; Bradi B Granger
Journal:  Am J Crit Care       Date:  2013-09       Impact factor: 2.228

Review 3.  Identification and management of alcohol withdrawal syndrome.

Authors:  Antonio Mirijello; Cristina D'Angelo; Anna Ferrulli; Gabriele Vassallo; Mariangela Antonelli; Fabio Caputo; Lorenzo Leggio; Antonio Gasbarrini; Giovanni Addolorato
Journal:  Drugs       Date:  2015-03       Impact factor: 9.546

4.  Racial variations in the incidence of severe alcohol withdrawal.

Authors:  Gar Ming Chan; Robert S Hoffman; Jeffrey A Gold; Paula J Whiteman; Lewis R Goldfrank; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2009-03

5.  The role of a medical toxicologist for assistance in the treatment of alcohol withdrawal syndrome.

Authors: 
Journal:  J Med Toxicol       Date:  2012-06

6.  Intoxications associated with agitation, tachycardia, hypertension, and Fever: differential diagnosis, evaluation, and management.

Authors:  Christopher J Keary; Shamim H Nejad; J J Rasimas; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2013-05-16

7.  The Assessment and Management Practices of Acute Alcohol Withdrawal: Results of a Nationwide Survey of Critical Care Pharmacists.

Authors:  Susanne Dyal; Robert MacLaren
Journal:  Hosp Pharm       Date:  2018-04-13

8.  Alcohol withdrawal and flumazenil: not for the faint of heart.

Authors:  Lewis S Nelson
Journal:  J Med Toxicol       Date:  2014-06

9.  Patient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review.

Authors:  Drayton A Hammond; Jordan M Rowe; Adrian Wong; Tessa L Wiley; Kristen C Lee; Sandra L Kane-Gill
Journal:  Hosp Pharm       Date:  2017-07-17

10.  Correlation Between Partial Pressure of Arterial Carbon Dioxide and End Tidal Carbon Dioxide in Patients with Severe Alcohol Withdrawal.

Authors:  Tariq Yousuf; Taylor Brinton; Jason Kramer; Basharath Khan; Jeffrey Ziffra; Dana Villines; Poorvi Shah; Tabassum Hanif
Journal:  Ochsner J       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.